Global Vaccine Market Value Estimated at $28.82 Billion by the End of 2018
The increasing focus on immunization programs by the government and influx of investments on vaccines research and development initiatives global companies are instilling substantial demand in the vaccine market. This resonates with the estimations published in a newly compiled IndustryARC report, that global vaccines market had a valuation of $28.82 billion as of 2018, and the demand for vaccines is poised to grow at a CAGR of 6.67% during the forecast period of 2019 to 2025.
The report is titled “
Vaccines Market: By Technology (Conjugate Vaccines, Inactivated, and
Others); By Disease Indication (Pneumococcal Disease, DTP, Others); By End User
(Pediatrics, Adults) & Geography Forecast (2019 - 2025).” The report documents
that in some of the populated countries with rapid economic growth rate, the
demand for new and non-EPI vaccines from the middle-class families is of significant
value which aspires growth of the vaccines market. However, the global vaccine
sales accounted for 18% of the value for low and middle- income countries, comprising
approximately 80% of the annual volume sold, according to WHO.
Vaccines Market: Leading Segments
Geographically, North America had the largest share in the vaccines market that translated to 39.70% in 2018. This is predominantly owing to robust healthcare infrastructure, the presence of numerous pioneering companies, and stringent rules and regulations in the US. Additionally, the increasing investments by the key players for various R&D initiative and the launch of new products in the U.S is contributing to the growth of the North America vaccine market. Higher literacy rate amalgamated with developing health awareness among individuals is increasing the uptake of vaccines. Moreover, state-of-the-art healthcare facilities and impeccable pharmaceuticals distribution networks adds business opportunities.
Likewise, according to the application
analysis in the report, the key application segment is found to be pediatrics.
The increasing diseases in children such as cholera, measles, chicken pox,
hepatitis certainly results in positive demand for pediatrics vaccines in the market. The application is expected to grow at a healthy CAGR of 7.04% during
the aforesaid forecast period.
Vaccines Market: Market Trends and Growth Drivers
Research and Development Activities
The increasing use of immunologic adjuvants in vaccines and the propelling emphasis on the therapeutic vaccines is supporting the market growth. The research and development of such ideologies are setting up tremendous scope of application in the market for vaccines.
The U.S government is emphasizing of the school-based vaccination for children, wherein in order to attend the public schools, vaccination is a requirement owing to the potential risk involved for other children when they are not vaccinated. This has highly increased the demand for vaccines in the U.S. market.
GVAP is an 8-year framework that aims to prevent the deaths of millions by providing equitable vaccination access for everyone in the community. This initiative is started with the aim of reaching out to the underprivileged and remote communities. GVAP initiative has had a positive impact on the vaccine market.
Lately, the licensed influenza vaccines are being designed to produce antibodies against the viral HA protein. These antibodies bind viruses to prevent infection. These are emerging vaccines in the market which is experiencing huge demand.
Vaccines Market: Competitive Landscape
Some of the key companies identified in the report that are currently holding majority shares in the global vaccine market are Johnson & Johnson, Merck & Co., Inc., Emergent BioSolutions, Serum Institute of India Ltd, Novavax, GlaxoSmithKline plc, Pfizer Inc., AstraZeneca. Plc, Merck & Co., Inc, and Sanofi S.A.
Talk to one of our sales representative
about the full report by providing your details in the link below:
Veterinary Vaccines Market
Influenza Vaccine Market
Therapeutic Vaccines Market
What can you expect from the
The vaccines market is prepared with the main agenda to cover the following 20 points:
1. Market Size by Product Categories & Application 11. Demand Analysis (Revenue & Volume)
2. Market trends & Relevant Market Data 12. Country level Analysis
3. Manufacturer Landscape 13. Competitor Analysis
4. Distributor Landscape 14. Market Shares Analysis
5. Pricing Analysis 15. Value Chain Analysis
6. Top 10 End user Analysis 16. Supply Chain Analysis
7. Product Benchmarking 17. Strategic Analysis
8. Product Developments 18. Current & Future Market Landscape Analysis
9. Mergers & Acquisition Analysis 19. Opportunity Analysis
10. Patent Analysis 20. Revenue and Volume Analysis
Frequently Asked Questions:
Q. Does IndustryARC provide
customized reports and charge additionally for limited customization?
: Yes, we can customize the report by
extracting data from our database of reports and annual subscription databases.
We can provide the following free customization:
1. Increase the level of data in application or end user industry.
2. Increase the number of countries in geography chapter.
3. Find out market shares for other smaller companies or companies which are of interest to you.
4. Company profiles can be requested based on your interest.
5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.
Any other custom requirements can be
discussed with our team, drop an e-mail to email@example.com to discuss more about our consulting
To request for a proposal, provide your
details in the below link:
Mr. Venkat Reddy
Email 1: firstname.lastname@example.org
Or Email 2: email@example.com
Contact Sales: +1-614-588-8538
: IndustryARC is a Research and
Consulting Firm that publishes more than 500 reports annually, in various
industries such as Agriculture, Automotive, Automation & Instrumentation,
Chemicals and Materials, Energy and Power, Electronics, Food and Beverages,
Information Technology, and Life sciences and Healthcare.